289 related articles for article (PubMed ID: 28074525)
41. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
[TBL] [Abstract][Full Text] [Related]
42. Expanding the spectrum of frontal fibrosing alopecia: a unifying concept.
Chew AL; Bashir SJ; Wain EM; Fenton DA; Stefanato CM
J Am Acad Dermatol; 2010 Oct; 63(4):653-60. PubMed ID: 20846567
[TBL] [Abstract][Full Text] [Related]
43. Alopecia areata in Korea (1982-1994).
Ro BI
J Dermatol; 1995 Nov; 22(11):858-64. PubMed ID: 8557859
[TBL] [Abstract][Full Text] [Related]
44. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.
Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444
[TBL] [Abstract][Full Text] [Related]
45. Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone.
Freyschmidt-Paul P; Hamm H; Happle R; Hoffmann R
Eur J Dermatol; 1999 Mar; 9(2):111-4. PubMed ID: 10066958
[TBL] [Abstract][Full Text] [Related]
46. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
47. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
48. Comparative study of the use of fractional CO
Nouh AH; Kadah AS; Said M
Dermatol Ther; 2022 Apr; 35(4):e15358. PubMed ID: 35119705
[TBL] [Abstract][Full Text] [Related]
49. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
50. Cicatricial eyebrow reconstruction with a dense-packing one- to two-hair grafting technique.
Wang J; Fan J
Plast Reconstr Surg; 2004 Nov; 114(6):1420-6. PubMed ID: 15509928
[TBL] [Abstract][Full Text] [Related]
51. Eyebrow transplantation.
Goldman GD
Dermatol Surg; 2001 Apr; 27(4):352-4. PubMed ID: 11298705
[TBL] [Abstract][Full Text] [Related]
52. Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment.
Ganzetti G; Campanati A; Simonetti O; Cataldi I; Giuliodori K; Offidani AM
Int J Immunopathol Pharmacol; 2011; 24(4):1087-91. PubMed ID: 22230416
[TBL] [Abstract][Full Text] [Related]
53. [Therapy of alopecia areata with diphenylcyclopropenone].
Kietzmann H; Hardung H; Christophers E
Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
[TBL] [Abstract][Full Text] [Related]
54. Multi-Concentration Level Patch Test Guided Diphenyl Cyclopropenone (DPCP) Treatment in Alopecia Totalis or Alopecia Universalis.
Thuangtong R; Varothai S; Triwongwaranat D; Rujitharanawong C
J Med Assoc Thai; 2017 Jan; 100(1):86-92. PubMed ID: 29911776
[TBL] [Abstract][Full Text] [Related]
55. Clinical Efficacy of Diphenylcyclopropenone Immunotherapy as Monotherapy for Multiple Viral Warts.
Park JY; Park BW; Cho EB; Park EJ; Kim KH; Kim KJ
J Cutan Med Surg; 2018; 22(3):285-289. PubMed ID: 29528750
[TBL] [Abstract][Full Text] [Related]
56. [Alopecia areata].
Friedli A; Harms M
Ther Umsch; 2002 May; 59(5):233-7. PubMed ID: 12090120
[TBL] [Abstract][Full Text] [Related]
57. DPCP for the treatment of alopecia areata.
Bolduc C; Shapiro J
Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
[TBL] [Abstract][Full Text] [Related]
58. Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2010 Oct; 37(10):888-93. PubMed ID: 20860739
[TBL] [Abstract][Full Text] [Related]
59. A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
Macey J; Kitchen H; Aldhouse NVJ; Edson-Heredia E; Burge R; Prakash A; King BA; Mesinkovska N
Br J Dermatol; 2022 May; 186(5):849-860. PubMed ID: 34811721
[TBL] [Abstract][Full Text] [Related]
60. Review of Superficial Cryotherapy for the Treatment of Alopecia Areata.
Kaiser M; Issa N; Yaghi M; Jimenez JJ; Issa NT
J Drugs Dermatol; 2023 Aug; 22(8):802-809. PubMed ID: 37556514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
